Cell Therapy by Mesenchymal Stromal Cells Versus Myoblasts in a Pig Model of Urinary Incontinence.

Autor: Knoll J; Department of Urology at UKT, Center for Medical Research, Eberhard-Karls-University, Tuebingen, Germany., Amend B; Department of Urology, University of Tuebingen Hospital, Tuebingen, Germany., Harland N; Department of Urology, University of Tuebingen Hospital, Tuebingen, Germany., Isser S; Department of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, Eberhard Karls University of Tübingen, Germany., Bézière N; Department of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, Eberhard Karls University of Tübingen, Germany.; Cluster of Excellence CMFI (EXC 2124) 'Controlling Microbes to Fight Infections,' Eberhard Karls University Tübingen, Germany., Kraushaar U; Naturwissenschaftlich-Medizinisches Institut, Reutlingen, Germany., Stenzl A; Department of Urology, University of Tuebingen Hospital, Tuebingen, Germany., Aicher WK; Department of Urology at UKT, Center for Medical Research, Eberhard-Karls-University, Tuebingen, Germany.
Jazyk: angličtina
Zdroj: Tissue engineering. Part A [Tissue Eng Part A] 2024 Jan; Vol. 30 (1-2), pp. 14-30.
DOI: 10.1089/ten.TEA.2023.0103
Abstrakt: The leading cause of stress urinary incontinence (SUI) in women is the urethral sphincter muscle deficiency caused by mechanical stress during pregnancy and vaginal delivery. In men, prostate cancer surgery and injury of local nerves and muscles are associated with incontinence. Current treatment often fails to satisfy the patient's needs. Cell therapy may improve the situation. We therefore investigated the regeneration potential of cells in ameliorating sphincter muscle deficiency and UI in a large animal model. Urethral sphincter deficiency was induced surgically in gilts by electrocautery and balloon dilatation. Adipose tissue-derived stromal cells (ADSCs) and myoblasts from Musculus semitendinosus were isolated from male littermates, expanded, characterized in depth for expression of marker genes and in vitro differentiation, and labeled. The cells were injected into the deficient sphincter complex of the incontinent female littermates. Incontinent gilts receiving no cell therapy served as controls. Sphincter deficiency and functional regeneration were recorded by monitoring the urethral wall pressure during follow-up by two independent methods. Cells injected were detected in vivo during follow-up by transurethral fluorimetry, ex vivo by fluorescence imaging, and in cryosections of tissues targeted by immunofluorescence and by polymerase chain reaction of the sex-determining region Y (SRY) gene. Partial spontaneous regeneration of sphincter muscle function was recorded in control gilts, but the sphincter function remained significantly below levels measured before induction of incontinence (67.03% ± 14.00%, n  = 6, p  < 0.05). Injection of myoblasts yielded an improved sphincter regeneration within 5 weeks of follow-up but did not reach significance compared to control gilts (81.54% ± 25.40%, n  = 5). A significant and full recovery of the urethral sphincter function was observed upon injection of ADSCs within 5 weeks of follow-up (100.4% ± 23.13%, n  = 6, p  < 0.05). Injection of stromal cells provoked slightly stronger infiltration of CD45 pos leukocytes compared to myoblasts injections and controls. The data of this exploratory study indicate that ADSCs inherit a significant potential to regenerate the function of the urethral sphincter muscle.
Databáze: MEDLINE